
Nature Biotechnology, Published online: 29 June 2023; doi:10.1038/s41587-023-01862-0Biogen’s drug Qalsody is the first drug to gain approval for a genetically defined form of ALS, but there is more to come as developers zoom in on a wide range of disease targets…
Read More